Plasminogen (PLG) was found, which is activated by the plasminogen activator and the broad-spectrum serine protease plasmin, and ultimately leads to the proteolytic degradation of the extracellular matrix (ECM), which is a key biological process that drives tumor cell motility and progression towards the invasive phenotype [35–37]. The gene discussed is PLG; the disease is neoplasm.